| Drug-induced diseases: prevention, detection, and management JE Tisdale, DA Miller ASHP, 2010 | 260 | 2010 |
| Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes”(KDIGO) Controversies Conference IC Macdougall, AJ Bircher, KU Eckardt, GT Obrador, CA Pollock, ... Kidney international 89 (1), 28-39, 2016 | 255 | 2016 |
| Estimation of creatinine clearance in morbidly obese patients JA Demirovic, AB Pai, MP Pai American Journal of Health-System Pharmacy 66 (7), 642-648, 2009 | 205 | 2009 |
| The incidence and importance of anaemia in patients undergoing cardiac surgery in the UK–the first Association of Cardiothoracic Anaesthetists national audit AA Klein, TJ Collier, MS Brar, C Evans, G Hallward, SN Fletcher, ... Anaesthesia 71 (6), 627-635, 2016 | 182 | 2016 |
| Symptom prioritization among adults receiving in-center hemodialysis: a mixed methods study JE Flythe, T Hilliard, G Castillo, K Ikeler, J Orazi, E Abdel-Rahman, AB Pai, ... Clinical Journal of the American Society of Nephrology 13 (5), 735-745, 2018 | 146 | 2018 |
| Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference JL Babitt, MF Eisenga, VH Haase, AV Kshirsagar, A Levin, F Locatelli, ... Kidney international 99 (6), 1280-1295, 2021 | 138 | 2021 |
| Skeletal muscle, cytokines, and oxidative stress in end-stage renal disease DSC Raj, EA Dominic, A Pai, F Osman, M Morgan, G Pickett, VO Shah, ... Kidney international 68 (5), 2338-2344, 2005 | 138 | 2005 |
| Reduced drug use and hospitalization rates in patients undergoing hemodialysis who received pharmaceutical care: a 2‐year, randomized, controlled study AB Pai, A Boyd, J Depczynski, IM Chavez, N Khan, H Manley Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 29 (12 …, 2009 | 132 | 2009 |
| Medication-related problems in CKD KE Cardone, S Bacchus, MM Assimon, AB Pai, HJ Manley Advances in chronic kidney disease 17 (5), 404-412, 2010 | 109 | 2010 |
| Prevalence and risk factors for visual impairment in preschool children: the Sydney Paediatric Eye Disease Study ASI Pai, JJ Wang, C Samarawickrama, G Burlutsky, KA Rose, R Varma, ... Ophthalmology 118 (8), 1495-1500, 2011 | 103 | 2011 |
| Medication reconciliation and therapy management in dialysis-dependent patients: need for a systematic approach AB Pai, KE Cardone, HJ Manley, WLS Peter, R Shaffer, M Somers, ... Clinical Journal of the American Society of Nephrology 8 (11), 1988-1999, 2013 | 100 | 2013 |
| Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis AB Pai, AV Boyd, CR McQuade, A Harford, JP Norenberg, PG Zager Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 27 (3 …, 2007 | 100 | 2007 |
| Considerations and challenges in defining optimal iron utilization in hemodialysis DM Charytan, AB Pai, CT Chan, DW Coyne, AM Hung, CP Kovesdy, ... Journal of the American Society of Nephrology 26 (6), 1238-1247, 2015 | 94 | 2015 |
| Fostering innovation in symptom management among hemodialysis patients: paths forward for insomnia, muscle cramps, and fatigue JE Flythe, T Hilliard, E Lumby, G Castillo, J Orazi, EM Abdel-Rahman, ... Clinical journal of the American Society of Nephrology 14 (1), 150-160, 2019 | 83 | 2019 |
| Association of birth parameters with OCT measured macular and retinal nerve fiber layer thickness YM Tariq, A Pai, H Li, S Afsari, GA Gole, G Burlutsky, P Mitchell Investigative ophthalmology & visual science 52 (3), 1709-1715, 2011 | 77 | 2011 |
| Health‐related quality of life is maintained in hemodialysis patients receiving pharmaceutical care: a 2‐year randomized, controlled study AB Pai, A Boyd, A Chavez, HJ Manley Hemodialysis International 13 (1), 72-79, 2009 | 68 | 2009 |
| Ferumoxytol: a silver lining in the treatment of anemia of chronic kidney disease or another dark cloud? AB Pai, AO Garba Journal of blood medicine, 77-85, 2012 | 64 | 2012 |
| Non-transferrin bound iron, cytokine activation and intracellular reactive oxygen species generation in hemodialysis patients receiving intravenous iron dextran or iron sucrose AB Pai, T Conner, CR McQuade, J Olp, P Hicks Biometals 24, 603-613, 2011 | 62 | 2011 |
| Effect of different intravenous iron preparations on lymphocyte intracellular reactive oxygen species generation and subpopulation survival A Gupta, J Zhuo, J Zha, S Reddy, J Olp, A Pai BMC nephrology 11, 1-5, 2010 | 57 | 2010 |
| Vancomycin dosing in high flux hemodialysis: a limited-sampling algorithm AB Pai, MP Pai American journal of health-system pharmacy 61 (17), 1812-1816, 2004 | 57 | 2004 |
